Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors

2021 ◽  
Author(s):  
Clément Morgat ◽  
Véronique Brouste ◽  
Adrien Chastel ◽  
Valérie Vélasco ◽  
Gaétan Macgrogan ◽  
...  
Keyword(s):  
Breast Tumors ◽  
Cellular Distribution ◽  
Biological Factors ◽  
Neurotensin Receptor ◽  
Neurotensin Receptor 1

scholarly journals Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice

Oncotarget ◽  
2014 ◽  
Vol 5 (18) ◽  
pp. 8235-8251 ◽  
Author(s):  
Sandra Dupouy ◽  
Van Kien Doan ◽  
Zherui Wu ◽  
Najat Mourra ◽  
Jin Liu ◽  
...  
Keyword(s):  
Breast Tumors ◽  
Neurotensin Receptor ◽  
Neurotensin Receptor 1

scholarly journals Neurotensin and neurotensin receptor 1 mRNA expression in song-control regions changes during development in male zebra finches

2018 ◽  
Vol 78 (7) ◽  
pp. 671-686
Author(s):  
Devin P. Merullo ◽  
Chinweike N. Asogwa ◽  
Miguel Sanchez-Valpuesta ◽  
Shin Hayase ◽  
Bikash R. Pattnaik ◽  
...  
Keyword(s):  
Mrna Expression ◽  
Zebra Finches ◽  
Neurotensin Receptor ◽  
Song Control ◽  
Neurotensin Receptor 1 ◽  
Control Regions

Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use

2019 ◽  
Vol 46 (10) ◽  
pp. 2199-2207 ◽  
Author(s):  
Tingting He ◽  
Mengzhe Wang ◽  
Hui Wang ◽  
Hongpei Tan ◽  
Yongxiang Tang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Neurotensin Receptor ◽  
Potential Biomarker ◽  
Neurotensin Receptor 1

scholarly journals Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Julian Budzinski ◽  
Simone Maschauer ◽  
Hiroyuki Kobayashi ◽  
Pierre Couvineau ◽  
Hannah Vogt ◽  
...  
Keyword(s):  
Binding Affinity ◽  
Receptor Interaction ◽  
Endosomal Trafficking ◽  
Receptor Ligands ◽  
Bivalent Ligands ◽  
Neurotensin Receptor ◽  
Neuropsychiatric Diseases ◽  
Dopamine D3 ◽  
Neurotensin Receptor 1 ◽  
G Protein Coupled

AbstractBivalent ligands are composed of two pharmacophores connected by a spacer of variable size. These ligands are able to simultaneously recognize two binding sites, for example in a G protein-coupled receptor heterodimer, resulting in enhanced binding affinity. Taking advantage of previously described heterobivalent dopamine-neurotensin receptor ligands, we demonstrate specific interactions between dopamine D3 (D3R) and neurotensin receptor 1 (NTSR1), two receptors with expression in overlapping brain areas that are associated with neuropsychiatric diseases and addiction. Bivalent ligand binding to D3R-NTSR1 dimers results in picomolar binding affinity and high selectivity compared to the binding to monomeric receptors. Specificity of the ligands for the D3R-NTSR1 receptor pair over D2R-NTSR1 dimers can be achieved by a careful choice of the linker length. Bivalent ligands enhance and stabilize the receptor-receptor interaction leading to NTSR1-controlled internalization of D3R into endosomes via recruitment of β-arrestin, highlighting a potential mechanism for dimer-specific receptor trafficking and signalling.

Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth

2019 ◽  
Vol 58 (12) ◽  
pp. 2230-2240
Author(s):  
Hiroto Tokumoto ◽  
Takao Setoguchi ◽  
Yoshinobu Saitoh ◽  
Hiromi Sasaki ◽  
Satoshi Nagano ◽  
...  
Keyword(s):  
Therapeutic Target ◽  
Undifferentiated Pleomorphic Sarcoma ◽  
Neurotensin Receptor ◽  
Pleomorphic Sarcoma ◽  
Neurotensin Receptor 1
Sign in / Sign up

Export Citation Format

Share Document